Efficacy News and Research

RSS
CytRx reports $4.4 million net loss for third quarter 2010

CytRx reports $4.4 million net loss for third quarter 2010

FDA authorizes Athersys' MultiStem Phase II clinical trial for ulcerative colitis

FDA authorizes Athersys' MultiStem Phase II clinical trial for ulcerative colitis

MAP Pharmaceuticals reports positive results from LEVADEX QT trial for migraine

MAP Pharmaceuticals reports positive results from LEVADEX QT trial for migraine

Santarus's budesonide MMX drug shows positive result for active ulcerative colitis

Santarus's budesonide MMX drug shows positive result for active ulcerative colitis

XenoPort third quarter net loss decreases to $19.9 million

XenoPort third quarter net loss decreases to $19.9 million

Tai Chi benefits individuals with arthritis

Tai Chi benefits individuals with arthritis

CARMAT signs agreement with Edwards Lifesciences for total artificial heart

CARMAT signs agreement with Edwards Lifesciences for total artificial heart

Blocking beta glucuronidase enzyme could eliminate side effects of CPT-11 in colon cancer treatment

Blocking beta glucuronidase enzyme could eliminate side effects of CPT-11 in colon cancer treatment

Vapor rub improves sleep for children with cold symptoms

Vapor rub improves sleep for children with cold symptoms

Apricus receives $733,437 grants under QTDP program

Apricus receives $733,437 grants under QTDP program

bitop includes first patient in Ectoin inhalation solution clinical trial for inflammation and airway obstruction

bitop includes first patient in Ectoin inhalation solution clinical trial for inflammation and airway obstruction

AAGL recommends vaginal or laparoscopic hysterectomies

AAGL recommends vaginal or laparoscopic hysterectomies

Amgen wins Scrip Best New Drug award for Prolia

Amgen wins Scrip Best New Drug award for Prolia

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

Inviragen to present data on CHIKV vaccine at ASTMH meeting

Inviragen to present data on CHIKV vaccine at ASTMH meeting

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

AiCuris to present data on AIC316 anti-HSV drug at Antivirals Congress

AiCuris to present data on AIC316 anti-HSV drug at Antivirals Congress

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Rockwell Medical third quarter sales increases 4.1% to $14.7 million

Rockwell Medical third quarter sales increases 4.1% to $14.7 million

Athersys secures three Therapeutic Discovery Project grants

Athersys secures three Therapeutic Discovery Project grants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.